Tecan Group AG (SWX:TECN)
Switzerland · Delayed Price · Currency is CHF | Market Cap | 1.72B -17.1% |
| Revenue (ttm) | 882.48M -5.5% |
| Net Income | -110.65M |
| EPS | -8.74 |
| Shares Out | 12.53M |
| PE Ratio | n/a |
| Forward PE | 21.67 |
| Dividend | 3.00 (2.18%) |
| Ex-Dividend Date | Apr 17, 2026 |
| Volume | 27,420 |
| Average Volume | 51,862 |
| Open | 137.80 |
| Previous Close | 137.30 |
| Day's Range | 134.80 - 137.90 |
| 52-Week Range | 110.60 - 177.50 |
| Beta | 1.11 |
| RSI | 52.41 |
| Earnings Date | Aug 11, 2026 |
About Tecan Group AG
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service. Tecan Group AG has ... [Read more]
Financial Performance
Financial StatementsNews
Tecan Appoints Camila Japur As CFO
(RTTNews) - Tecan Group AG (TCHBF, TCGGY, TECN.SW), a Swiss company providing laboratory instruments and solutions, on Monday announced the appointment of Camila Japur as Chief Financial Officer, effe...
Q3 2025 Qualitative Update: Tecan reports mid-single-digit local currency growth in the third quarter and confirms full-year 2025 outlook
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Q3 2025 Qualitative Update: Tecan reports mid-single-digit local currency growth in the third quarter and confir...